Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating efficacy, safety, and pharmacokinetics of ES-481 in adults with drug resistant epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy

Drugs mentioned

• ES-481

Snippet

Sponsor: ES Therapeutics Australia Pty Ltd | Conditions: Drug Resistant Epilepsy | Phase 2 | Status: UNKNOWN